Why is Colinz Labs falling/rising?

As of 17-Sep, Colinz Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 40.41, which represents a decrease of Rs 2.08 or 4.9%. The stock has underperformed its sector by 4.94% today, following a trend reversal after two consecutive days of gains. It reached an intraday high of Rs 44.6 but fell to a low of Rs 40.37, indicating significant volatility with a wide trading range of Rs 4.23. Over the past week, the stock has seen a return of -1.20%, and it has also underperformed the Sensex over the past month and year-to-date, with returns of -6.63% and -42.07%, respectively. The company's weak long-term fundamentals, including a negative CAGR growth in net sales and a low return on equity, contribute to the stock's poor performance.
In the broader market context, Colinz Laboratories Ltd's performance contrasts sharply with the Sensex, which has gained 1.56% over the past week and 2.60% over the past month. The stock's liquidity is adequate, but there has been a decline in investor participation, with delivery volume falling by 7.56% against the five-day average. The company's financial health is concerning, as it has a poor EBIT to interest ratio and has generated a return of -34.29% over the past year, indicating a lack of profitability and growth compared to its peers. Overall, these factors suggest that the stock is facing significant challenges, leading to its current downward trend.